Trial Profile

Remifentanil Tapering and Post-adenotonsillectomy Pain in Children: a Randomised, Placebo Controlled, Double Blind Study

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Remifentanil (Primary)
Indications Perioperative pain
Focus Therapeutic Use

Most Recent Events

18 Aug 2023 Status changed from active, no longer recruiting to discontinued.
11 Feb 2022 Planned End Date changed from 1 Jul 2022 to 1 Jul 2024.
11 Feb 2022 Planned primary completion date changed from 1 Jan 2022 to 1 Jan 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com